Rossi, Roberta Elisa
 Distribuzione geografica
Continente #
NA - Nord America 1.754
AS - Asia 791
EU - Europa 243
SA - Sud America 136
Continente sconosciuto - Info sul continente non disponibili 128
AF - Africa 24
OC - Oceania 3
Totale 3.079
Nazione #
US - Stati Uniti d'America 1.684
SG - Singapore 331
CN - Cina 192
IT - Italia 106
VN - Vietnam 100
BR - Brasile 92
HK - Hong Kong 47
CA - Canada 28
FR - Francia 28
BD - Bangladesh 26
GB - Regno Unito 24
IN - India 20
MX - Messico 19
AR - Argentina 14
DE - Germania 12
BE - Belgio 11
IQ - Iraq 10
PL - Polonia 10
CO - Colombia 9
MY - Malesia 9
TR - Turchia 9
PK - Pakistan 8
FI - Finlandia 7
ZA - Sudafrica 7
CL - Cile 5
EC - Ecuador 5
ID - Indonesia 5
JM - Giamaica 5
SA - Arabia Saudita 5
UZ - Uzbekistan 5
CR - Costa Rica 4
ES - Italia 4
IE - Irlanda 4
MA - Marocco 4
PY - Paraguay 4
RU - Federazione Russa 4
SE - Svezia 4
VE - Venezuela 4
AU - Australia 3
GE - Georgia 3
HN - Honduras 3
HU - Ungheria 3
IR - Iran 3
NL - Olanda 3
RO - Romania 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
AE - Emirati Arabi Uniti 2
BO - Bolivia 2
CH - Svizzera 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
EE - Estonia 2
GT - Guatemala 2
JO - Giordania 2
JP - Giappone 2
KE - Kenya 2
NG - Nigeria 2
NI - Nicaragua 2
OM - Oman 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
UA - Ucraina 2
AL - Albania 1
AT - Austria 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BM - Bermuda 1
CD - Congo 1
CV - Capo Verde 1
CY - Cipro 1
DK - Danimarca 1
EG - Egitto 1
GR - Grecia 1
KY - Cayman, isole 1
KZ - Kazakistan 1
LB - Libano 1
LV - Lettonia 1
LY - Libia 1
MM - Myanmar 1
PE - Perù 1
PR - Porto Rico 1
QA - Qatar 1
RS - Serbia 1
SI - Slovenia 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TW - Taiwan 1
YE - Yemen 1
Totale 2.951
Città #
Dallas 368
San Jose 147
Singapore 146
Council Bluffs 130
Santa Clara 86
Beijing 63
Ashburn 56
Hong Kong 46
Milan 40
Los Angeles 28
Ho Chi Minh City 27
Hanoi 21
Phoenix 21
Princeton 20
The Dalles 17
Chicago 15
Da Nang 12
New York 12
Rome 12
Shanghai 12
São Paulo 12
Atlanta 11
Buffalo 11
Philadelphia 11
Abbeville 10
Assago 10
Queens 10
Mexico City 9
Charlotte 8
Houston 8
Helsinki 7
Kannapolis 7
Miami 7
San Francisco 7
Seattle 7
Haiphong 6
Lokeren 6
Toronto 6
Warsaw 6
Baghdad 5
Brooklyn 5
Cleveland 5
Dhaka 5
Figino 5
Mesa 5
Pittsburgh 5
San Antonio 5
Tashkent 5
Chennai 4
Dublin 4
Englewood 4
Frankfurt am Main 4
Indianapolis 4
Istanbul 4
Naples 4
Newark 4
North Bergen 4
Paris 4
Prineville 4
Richmond 4
Rio Rancho 4
Santa Ana 4
Santiago 4
Alexandria 3
Anaheim 3
Antwerp 3
Belo Horizonte 3
Boardman 3
Bogotá 3
Bologna 3
Columbus 3
Corpus Christi 3
Fort Worth 3
Fredericksburg 3
Hillsboro 3
Lahore 3
London 3
Louisville 3
Marseille 3
Milwaukee 3
Minneapolis 3
Minot 3
Orem 3
Oxnard 3
Petaling Jaya 3
Queen Creek 3
Raleigh 3
Rancho Cucamonga 3
San José 3
Tbilisi 3
The Bronx 3
Uberlândia 3
Waltham 3
Amman 2
Amsterdam 2
Augusta 2
Austin 2
Azusa 2
Benin City 2
Bethpage 2
Totale 1.647
Nome #
CLINICAL PRESENTATION OF BONE METASTASES IN NEUROENDOCRINE TUMORS: A RETROSPECTIVE COHORT STUDY 402
Urinary 5-Hydroxyindolacetic Acid Measurements in Patients with Neuroendocrine Tumor-Related Carcinoid Syndrome: State of the Art 63
Neuroendocrine tumors in patients with inflammatory bowel disease: a case series 63
Management of type I gastric-neuroendocrine tumors: the less the better? 63
Diagnostic Yield of Small Bowel Videocapsule Endoscopy in Patients with Iron Deficiency Anemia. A Systematic Review and meta-analysis 62
Risk of preoperative understaging of duodenal neuroendocrine neoplasms: a plea for caution in the treatment strategy 60
Distinguishing features of autoimmune gastritis depending on previous H. pylori infection or positivity to anti-parietal cell antibodies: results from the Autoimmune gastRitis Italian netwOrk Study grOup (ARIOSO) 60
Duodenal Gastric Metaplasia and Duodenal Neuroendocrine Neoplasms: More Than a Simple Coincidence? 59
Multidisciplinary Approach to the Diagnosis of Occult Primary Neuroendocrine Neoplasm: A Clinical Challenge 58
Management of Asymptomatic Sporadic Nonfunctioning Pancreatic Neuroendocrine Neoplasms (ASPEN) ≤2 cm: Study Protocol for a Prospective Observational Study 58
Outcome of Endoscopic Resection of Rectal Neuroendocrine Tumors ≤ 10 mm 54
Small bowel lesions in patients with iron deficiency anaemia without overt bleeding: a multicentre study 52
Prevalence of Osteopathy In Chronic Pancreatitis: A Systematic Review and Meta-Analysis 48
Clinical presentation of celiac disease in adult patients: current real-life experience 48
Endoscopic Resection for Duodenal Neuroendocrine Neoplasms between 10 and 20 mm—A Systematic Review and Meta-Analysis 41
Co-existing Neuroendocrine Tumors in the Ileum and Pancreas: A Clinico-Pathological Challenge 41
Real-Time Gastric Juice Analysis to Rule Out the Presence of Autoimmune Gastritis: A Case-Control Study 36
Small Bowel Imaging in Celiac Disease: Is there a role for Small Bowel Ultrasound? 35
Chromogranin A in diagnosing and monitoring patients with gastro-entero-pancreatic neuroendocrine neoplasms : a large series from a single institution 31
Anti-tumour necrosis factor agent and liver injury : literature review, recommendations for management 30
ALPHA-FETOPROTEIN IN GASTRO-ENTERO-PANCREATIC NEUROENDOCRINE NEOPLASMS: A SINGLE CENTRE STUDY 30
A wait-and-watch approach to small pancreatic neuroendocrine tumors : Prognosis and survival 29
Liver resection and transplantation for metastases from gastroenteropancreatic neuroendocrine tumors 28
ASO Author Reflections: Heterogeneity of Duodenal Neuroendocrine Tumors 27
Chromogranin A as a predictor of radiological disease progression in neuroendocrine tumours 27
Chronic autoimmune atrophic gastritis associated with primary hyperparathyroidism: A transversal prospective study 26
ASO Author Reflections: Heterogeneity of Duodenal Neuroendocrine Tumors 25
Can Neutrophil-to-Lymphocyte Ratio (NLR) Predict Clinical Outcomes of Pancreatic Neuroendocrine Tumors (PanNETs)? 25
Cabozantinib in the Treatment of Neuroendocrine Neoplasms: Insights across Different Tumor Origins 25
Endoscopic techniques to detect small-bowel neuroendocrine tumors: A literature review 25
Duodenal neuroendocrine neoplasms: a still poorly recognized clinical entity 25
Gastrinoma and Zollinger Ellison syndrome: A roadmap for the management between new and old therapies 24
Plasma chromogranin a response to octreotide test: Prognostic value for clinical outcome in endocrine digestive tumors 23
Nutritional deficiencies in inflammatory bowel disease: Therapeutic approaches 23
Chromogranin A as a Marker in the Follow-up of Gastro-Entero-Pancreatic Neuroendocrine Neoplasms (GEP-NENs). A Systematic Review 23
Letter: Breaking new ground—Understanding the role of ATI-free diet in managing MASLD 23
NEN Gain or NEN Loss: Endoscopic Resection for Rectal Neuroendocrine Neoplasms < 15 mm 23
An esophageal gastrointestinal stromal tumor in a patient with MEN1-related pancreatic gastrinoma : an unusual association and review of the literature 21
Metastatic pheochromocytomas and paragangliomas: where are we? 21
New and Emerging Systemic Therapeutic Options for Advanced Cholangiocarcinoma 21
Response and relapse rates after treatment with long-acting somatostatin analogs in multifocal or recurrent type-1 gastric carcinoids : a systematic review and meta-analysis 21
Alpha-Fetoprotein in Gastro-Entero-Pancreatic Neuroendocrine Neoplasms: A Single Centre Study 21
CAN NEUTROPHIL-TO-LYMPHOCYTE RATIO (NLR) PREDICT CLINICAL OUTCOMES OF PANCREATIC NEUROENDOCRINE TUMORS (PanNETs)? 20
Chromogranin A in the Follow-up of Gastroenteropancreatic Neuroendocrine Neoplasms: Is It Really Game Over? A Systematic Review and Meta-analysis 20
Carcinoid syndrome and hyperinsulinemic hypoglycemia associated with neuroendocrine neoplasms: A critical review on clinical and pharmacological management 20
Intraductal papillary neoplasm of the bile duct: The new frontier of biliary pathology 20
The Role of Combination of Molecular Imaging Studies in the Follow-Up of Patients With Advanced Neuroendocrine Tumors 20
Biliary Stone Disease in Patients with Neuroendocrine Tumors Treated with Somatostatin Analogs: A Multicenter Study 18
Synchronous duodenal neuroendocrine neoplasm and congenital factor XIII deficiency: case report and review of the literature 18
The Increasing Incidence of Neuroendocrine Neoplasms Worldwide: Current Knowledge and Open Issues 18
Case report of multimodality treatment for metastatic parathyroid hormone-related peptide-secreting pancreatic neuroendocrine tumour 18
Exploring specific alterations at the explicit and perceptual levels in sense of ownership, agency, and body schema in Functional Motor Disorder: A pilot comparative study with Irritable Bowel Syndrome 18
CHROMOGRANIN A AS A MARKER IN THE FOLLOWUP OF GASTRO-ENTERO-PANCREATIC NEUROENDOCRINE NEOPLASMS (GEP-NENS). A SYSTEMATIC REVIEW 18
Rectal neuroendocrine tumors: Current advances in management, treatment, and surveillance 18
Endoscopic techniques to detect small-bowel neuroendocrine tumors: A literature review 18
Adjuvant radiotherapy in urothelial neuroendocrine carcinoma 18
Safety of loco-regional treatments in neuroendocrine liver metastases compared to an hepato-cellular carcinoma cohort: a single-center study 17
Clinical treatment of cholangiocarcinoma: an updated comprehensive review 17
Differential Diagnosis and Management of Diarrhea in Patients with Neuroendocrine Tumors 17
Second primary neoplasms in patients with lung and gastroenteropancreatic neuroendocrine neoplasms: Data from a retrospective multi-centric study 17
Pathophysiology and treatment of exercise-associated hyponatremia 17
Functional Neuroimaging in Irritable Bowel Syndrome: A Systematic Review Highlights Common Brain Alterations With Functional Movement Disorders 16
Transient elastography in patients with celiac disease : a noninvasive method to detect liver involvement associated with celiac disease 16
Predictive Factors of Tumor Recurrence after Radical Surgery for Gastro-Entero-Pancreatic Neuroendocrine Neoplasms (GEP-NENs): Identification of High-Risk Subgroups 16
Different Survival Outcomes of Small Bowel Adenocarcinomas and T-Cell Lymphomas Associated With Celiac Disease 16
Vitamin D Deficiency as a Risk Factor in Pancreatic Neuroendocrine Neoplasms: Report from a Series at a Single Institute 16
Paradoxical association between dyspepsia and autoimmune chronic atrophic gastritis: Insights into mechanisms, pathophysiology, and treatment options 16
Gender perspective in Lung Neuroendocrine Tumors: a critical review 15
Prognostic value, clinical relevance, and methodological gaps of tumor burden in neuroendocrine tumors (NETs): A systematic review of phase III randomized trials of medical therapies 15
Response to Wiwanitkit 15
Targeting neuroendocrine tumors with octreotide and lanreotide: Key points for clinical practice from NET specialists 15
Treatment of liver metastases in patients with digestive neuroendocrine tumors 15
Double-Balloon Enteroscopy in Detecting Small-Bowel Neuroendocrine Neoplasms: A Single-Center Prospective Study 15
Emerging Treatment Options for Neuroendocrine Neoplasms of Unknown Primary Origin: Current Evidence and Future Perspectives 15
Unusually aggressive type 1 gastric carcinoid: A case report with a review of the literature 14
Gender-related differences in celiac disease presentation and follow-up in adult patients 14
Nutrition and pancreatic cancer 14
Gastrinoma and neurofibromatosis type 2: the first case report and review of the literature 14
The Role of Diet and Supplements in the Prevention and Progression of COVID-19: Current Knowledge and Open Issues 14
Somatostatin analogues in functioning gastroenteropancreatic neuroendocrine tumours : Literature review, clinical recommendations and schedules 14
Endoscopic techniques for diagnosis and treatment of gastroentero-pancreatic neuroendocrine neoplasms: Where we are 14
Eterogeneity of Duodenal Neuroendocrine Tumors: A Multi-Centre Experience in Italy 14
Recent Advances in the Management of Typical and Atypical Lung Carcinoids 14
Clinical practice guidelines for the management of non-functioning advanced GEP-NENs: a GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology (AIOM) in collaboration with the Italian Association for Neuroendocrine Tumors (ITANET) 14
Primary sclerosing cholangitis associated with inflammatory bowel disease : An update 13
COVID-19 in long-term liver transplant patients: preliminary experience from an Italian transplant centre in Lombardy 13
Therapy for metastatic pancreatic neuroendocrine tumors 13
Tyrosine kinase inhibitors for unresectable hepatocellular carcinoma in adults 13
Heterogeneity of Duodenal Neuroendocrine Tumors: An Italian Multi-center Experience 13
Heterogeneity of Duodenal Neuroendocrine Tumors: A Multi-Centre Experience in Italy 13
Improved management of grade B biliary leaks after complex liver resections using gadoxetic acid disodium–enhanced magnetic resonance cholangiography 13
Hepatic hemangioma in celiac patients : data from a large consecutive series 13
Assessing the effectiveness and safety of surufatinib versus everolimus or sunitinib in advanced neuroendocrine neoplasms: insights from a real-world, retrospective cohort study using propensity score and inverse probability treatment weighting analysis 13
Authorship of Italian medical literature on neuroendocrine neoplasms: any gender gap? 13
Sporadic and MEN1-related gastrinoma and Zollinger–Ellison syndrome: differences in clinical characteristics and survival outcomes 13
Long-term outcomes of resection versus transplantation for neuroendocrine liver metastases meeting the Milan criteria 13
Reply 13
Functioning neuroendocrine tumors (NET): Minimum requirements for a NET specialist 12
Clinical and Endoscopic-Histological Features of Multifocal and Corpus-Restricted Atrophic Gastritis Patients With Non-Cardia Gastric Cancer or Dysplasia: A Multicenter, Cross-Sectional Study 12
Prostate cancer and the influence of dietary factors and supplements: A systematic review 12
Totale 2.793
Categoria #
all - tutte 25.763
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.763


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20227 0 0 0 0 0 0 0 0 3 1 3 0
2022/202310 4 0 2 0 0 0 0 0 2 2 0 0
2023/202427 1 3 4 0 0 2 1 2 0 0 3 11
2024/2025137 2 7 7 0 0 10 15 10 25 27 12 22
2025/20261.668 56 26 360 63 18 21 116 386 282 141 93 106
2026/20271.230 202 211 644 173 0 0 0 0 0 0 0 0
Totale 3.079